Randox QC Launch RIQAS CO-Oximetry EQA / PT Programme
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Co-oximetry is a methodology that measures the levels of the oxygen-carrying protein haemoglobin, which is the chief component of red blood cells. Co-oximetry is a useful tool in that it helps determine the levels of various forms of haemoglobin and can be used to diagnose a variety of conditions related to oxygen content in blood.
Oxygen content is an important indicator of oxygen transport within the body. The oxygen transport of arterial blood is used to evaluate the ability of transporting oxygen from the lungs to the tissue.
As part of their ongoing growth and development Randox Quality Control are pleased to announce the launch of a new CO-Oximetry programme to complement their existing Blood Gas programme. Combining 7 parameters in a user-friendly, liquid ready-to-use format, the new RIQAS CO-Oximetry EQA programme has been designed with consolidation and convenience in mind – it’s even suitable for use in point-of-care testing.
RIQAS is the world’s largest EQA scheme with 45,000 participants and 33 programmes ensuring peer groups are maximised. The added benefit of comprehensive yet user-friendly reports available within 72 hours of the submission date allowing corrective action to be taken in a timely manner, saving time, money, and reputation by eliminating the need for expensive retesting, providing peace of mind.
“The launch of our new CO-Oximetry programme means we now offer a complete EQA solution for blood gas testing.”
- Lynsey Adams, Quality Control Marketing Manager
Oxygen content is an important indicator of oxygen transport within the body. The oxygen transport of arterial blood is used to evaluate the ability of transporting oxygen from the lungs to the tissue.
As part of their ongoing growth and development Randox Quality Control are pleased to announce the launch of a new CO-Oximetry programme to complement their existing Blood Gas programme. Combining 7 parameters in a user-friendly, liquid ready-to-use format, the new RIQAS CO-Oximetry EQA programme has been designed with consolidation and convenience in mind – it’s even suitable for use in point-of-care testing.
RIQAS is the world’s largest EQA scheme with 45,000 participants and 33 programmes ensuring peer groups are maximised. The added benefit of comprehensive yet user-friendly reports available within 72 hours of the submission date allowing corrective action to be taken in a timely manner, saving time, money, and reputation by eliminating the need for expensive retesting, providing peace of mind.
“The launch of our new CO-Oximetry programme means we now offer a complete EQA solution for blood gas testing.”
- Lynsey Adams, Quality Control Marketing Manager
